Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans.
Fan L, Liu J, Hu W, Chen Z, Lan J, Zhang T, Zhang Y, Wu X, Zhong Z, Zhang D, Zhang J, Qin R, Chen H, Zong Y, Zhang J, Chen B, Jiang J, Cheng J, Zhou J, Gao Z, Liu Z, Chai Y, Fan J, Wu P, Chen Y, Zhu Y, Wang K, Yuan Y, Huang P, Zhang Y, Feng H, Song K, Zeng X, Zhu W, Hu X, Yin W, Chen W, Wang J.
Fan L, et al. Among authors: zhang t, zhang d, zhang j, zhang y.
Cell Res. 2024 Mar 15. doi: 10.1038/s41422-024-00945-0. Online ahead of print.
Cell Res. 2024.
PMID: 38491170